Global Burn and Scald Medicine Supply, Demand and Key Producers, 2025-2031

Description

The global Burn and Scald Medicine market size is expected to reach $ 615 million by 2031, rising at a market growth of 3.6% CAGR during the forecast period (2025-2031).

Burns are a common traumatic disease caused by physical or chemical factors, such as heat, chemistry, electric current and radiation. Small-area burns only cause damage to the skin and (or) mucosal tissue or the corresponding deep tissue. However, larger-area burns can cause functional, metabolic and morphological changes in various systems of the body to varying degrees, causing severe systemic reactions and visceral damage in the injured, and complications such as shock, sepsis and multiple organ failure, with a high mortality rate. The healing and treatment process of burn wounds is complex and takes a long time. After the wound heals, sequelae such as scar contracture and functional impairment may remain. Therefore, burns, especially large-area burns, are the most complex and serious traumatic diseases. In order to treat patients with large-area severe burns, in addition to the need for specialists to have solid basic medical knowledge and experience in burns, other departments such as general surgery, cardiothoracic surgery, urology, orthopedics, anesthesiology and internal medicine need to work together for consultation and treatment to form a team to achieve success. This is the result of collective efforts, cooperation and collaborative work. Burn and scald medicines refer to medicines used to treat skin or tissue damage caused by heat (such as flames, hot water, steam), chemicals, electric current or radiation. The main functions of these medicines are to relieve pain, prevent infection, promote wound healing and reduce scar formation. According to the severity and type of burns, burn and scald medicines can be divided into topical medicines, oral medicines and new therapies. The statistical object of this article is topical medicines for burns and scalds.

The global market for burn and scald medicine is showing a steady growth trend, mainly driven by the improvement of medical standards, the increase in the incidence of burn accidents and the increase in people's health awareness. With the development of industrialization, the acceleration of urbanization and the increase in accidental injuries in the home, the demand for burn and scald treatment drugs is gradually increasing. New drugs are constantly emerging in the field of modern medicine, including growth factor drugs, bioengineered skin substitutes and silver-containing antibacterial drugs. These innovative therapies effectively improve the healing speed of wounds and reduce the risk of infection. At the same time, Chinese herbal medicine and natural plant extracts are gradually gaining market attention as auxiliary treatments, especially in Asia. The North American and European markets are dominated by advanced medical technology and high medical expenditures, while the Asia-Pacific region has become the fastest growing region due to its large population base, increased medical investment and increased public health awareness. The challenges facing the market include high drug research and development costs, complex approval processes, drug side effects and drug resistance. Major players focus on R&D innovation, expanding indications, and improving competitiveness through mergers and acquisitions and strategic cooperation. In the future, with the development of precision medicine and the promotion of personalized treatment plans, the market for burn and scald drugs is expected to maintain steady growth, especially drugs with significant wound healing effects and low side effects, which have greater market potential.

This report studies the global Burn and Scald Medicine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Burn and Scald Medicine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2024 as the base year. This report explores demand trends and competition, as well as details the characteristics of Burn and Scald Medicine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Burn and Scald Medicine total production and demand, 2020-2031, (K Units)
Global Burn and Scald Medicine total production value, 2020-2031, (USD Million)
Global Burn and Scald Medicine production by region & country, production, value, CAGR, 2020-2031, (USD Million) & (K Units), (based on production site)
Global Burn and Scald Medicine consumption by region & country, CAGR, 2020-2031 & (K Units)
U.S. VS China: Burn and Scald Medicine domestic production, consumption, key domestic manufacturers and share
Global Burn and Scald Medicine production by manufacturer, production, price, value and market share 2020-2025, (USD Million) & (K Units)
Global Burn and Scald Medicine production by Type, production, value, CAGR, 2020-2031, (USD Million) & (K Units)
Global Burn and Scald Medicine production by Application, production, value, CAGR, 2020-2031, (USD Million) & (K Units)
This report profiles key players in the global Burn and Scald Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mebao Pharmaceutical Technology Group, B. Braun, Integra LifeSciences, Jinyao Darentang, Smith & Nephew, Yangtze River Pharmaceutical Group, STADA Thornton & Ross, Kenvue Brands LLC, Changchun Overseas Pharmaceutical Group Co., Ltd., Orkla Health, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Burn and Scald Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2020-2031 by year with 2024 as the base year, 2025 as the estimate year, and 2026-2031 as the forecast year.

Global Burn and Scald Medicine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Burn and Scald Medicine Market, Segmentation by Type:
    Ointment
    Spray
    Oil
    Other

Global Burn and Scald Medicine Market, Segmentation by Application:
    Hospitals and Clinics
    Retail Pharmacies
    E-commerce Platforms
    Other

Companies Profiled:
    Mebao Pharmaceutical Technology Group
    B. Braun
    Integra LifeSciences
    Jinyao Darentang
    Smith & Nephew
    Yangtze River Pharmaceutical Group
    STADA Thornton & Ross
    Kenvue Brands LLC
    Changchun Overseas Pharmaceutical Group Co., Ltd.
    Orkla Health
    Guangdong Hengjian Pharmaceutical
    Otsuka Pharmaceutical Co., Ltd.
    Tonghua Maoxiang Pharmaceutical Co., Ltd.
    Cipla
    Tanabe Mitsubishi Pharmaceuticals
    Chongqing Xixuan Biotechnology Co., Ltd.
    Quest Products, LLC
    Jianmin Group Yekai Thai Pharmaceutical (Suizhou)
    Acme United Corp.
    Dongwha Pharm
    China Resources Pharmaceutical Group
    Safetec Of America
    Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.
    North China Pharmaceutical Hebei Huanuo
    Xiangxi Hongcheng Pharmaceutical
    Hebei Aoxing Group Pharmaceuticals
    Jilin Aodong Pharmaceutical Group
    Beijing Tongrentang
    Henan Quanyu Pharmaceuticals
    Chengdu First Pharmaceuticals

Key Questions Answered:
1. How big is the global Burn and Scald Medicine market?
2. What is the demand of the global Burn and Scald Medicine market?
3. What is the year over year growth of the global Burn and Scald Medicine market?
4. What is the production and production value of the global Burn and Scald Medicine market?
5. Who are the key producers in the global Burn and Scald Medicine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Burn and Scald Medicine Introduction
    1.2 World Burn and Scald Medicine Supply & Forecast
        1.2.1 World Burn and Scald Medicine Production Value (2020 & 2024 & 2031)
        1.2.2 World Burn and Scald Medicine Production (2020-2031)
        1.2.3 World Burn and Scald Medicine Pricing Trends (2020-2031)
    1.3 World Burn and Scald Medicine Production by Region (Based on Production Site)
        1.3.1 World Burn and Scald Medicine Production Value by Region (2020-2031)
        1.3.2 World Burn and Scald Medicine Production by Region (2020-2031)
        1.3.3 World Burn and Scald Medicine Average Price by Region (2020-2031)
        1.3.4 North America Burn and Scald Medicine Production (2020-2031)
        1.3.5 Europe Burn and Scald Medicine Production (2020-2031)
        1.3.6 China Burn and Scald Medicine Production (2020-2031)
        1.3.7 Japan Burn and Scald Medicine Production (2020-2031)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Burn and Scald Medicine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Burn and Scald Medicine Major Market Trends

2 Demand Summary
    2.1 World Burn and Scald Medicine Demand (2020-2031)
    2.2 World Burn and Scald Medicine Consumption by Region
        2.2.1 World Burn and Scald Medicine Consumption by Region (2020-2025)
        2.2.2 World Burn and Scald Medicine Consumption Forecast by Region (2026-2031)
    2.3 United States Burn and Scald Medicine Consumption (2020-2031)
    2.4 China Burn and Scald Medicine Consumption (2020-2031)
    2.5 Europe Burn and Scald Medicine Consumption (2020-2031)
    2.6 Japan Burn and Scald Medicine Consumption (2020-2031)
    2.7 South Korea Burn and Scald Medicine Consumption (2020-2031)
    2.8 ASEAN Burn and Scald Medicine Consumption (2020-2031)
    2.9 India Burn and Scald Medicine Consumption (2020-2031)

3 World Manufacturers Competitive Analysis
    3.1 World Burn and Scald Medicine Production Value by Manufacturer (2020-2025)
    3.2 World Burn and Scald Medicine Production by Manufacturer (2020-2025)
    3.3 World Burn and Scald Medicine Average Price by Manufacturer (2020-2025)
    3.4 Burn and Scald Medicine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Burn and Scald Medicine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Burn and Scald Medicine in 2024
        3.5.3 Global Concentration Ratios (CR8) for Burn and Scald Medicine in 2024
    3.6 Burn and Scald Medicine Market: Overall Company Footprint Analysis
        3.6.1 Burn and Scald Medicine Market: Region Footprint
        3.6.2 Burn and Scald Medicine Market: Company Product Type Footprint
        3.6.3 Burn and Scald Medicine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Burn and Scald Medicine Production Value Comparison
        4.1.1 United States VS China: Burn and Scald Medicine Production Value Comparison (2020 & 2024 & 2031)
        4.1.2 United States VS China: Burn and Scald Medicine Production Value Market Share Comparison (2020 & 2024 & 2031)
    4.2 United States VS China: Burn and Scald Medicine Production Comparison
        4.2.1 United States VS China: Burn and Scald Medicine Production Comparison (2020 & 2024 & 2031)
        4.2.2 United States VS China: Burn and Scald Medicine Production Market Share Comparison (2020 & 2024 & 2031)
    4.3 United States VS China: Burn and Scald Medicine Consumption Comparison
        4.3.1 United States VS China: Burn and Scald Medicine Consumption Comparison (2020 & 2024 & 2031)
        4.3.2 United States VS China: Burn and Scald Medicine Consumption Market Share Comparison (2020 & 2024 & 2031)
    4.4 United States Based Burn and Scald Medicine Manufacturers and Market Share, 2020-2025
        4.4.1 United States Based Burn and Scald Medicine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Burn and Scald Medicine Production Value (2020-2025)
        4.4.3 United States Based Manufacturers Burn and Scald Medicine Production (2020-2025)
    4.5 China Based Burn and Scald Medicine Manufacturers and Market Share
        4.5.1 China Based Burn and Scald Medicine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Burn and Scald Medicine Production Value (2020-2025)
        4.5.3 China Based Manufacturers Burn and Scald Medicine Production (2020-2025)
    4.6 Rest of World Based Burn and Scald Medicine Manufacturers and Market Share, 2020-2025
        4.6.1 Rest of World Based Burn and Scald Medicine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Burn and Scald Medicine Production Value (2020-2025)
        4.6.3 Rest of World Based Manufacturers Burn and Scald Medicine Production (2020-2025)

5 Market Analysis by Type
    5.1 World Burn and Scald Medicine Market Size Overview by Type: 2020 VS 2024 VS 2031
    5.2 Segment Introduction by Type
        5.2.1 Ointment
        5.2.2 Spray
        5.2.3 Oil
        5.2.4 Other
    5.3 Market Segment by Type
        5.3.1 World Burn and Scald Medicine Production by Type (2020-2031)
        5.3.2 World Burn and Scald Medicine Production Value by Type (2020-2031)
        5.3.3 World Burn and Scald Medicine Average Price by Type (2020-2031)

6 Market Analysis by Application
    6.1 World Burn and Scald Medicine Market Size Overview by Application: 2020 VS 2024 VS 2031
    6.2 Segment Introduction by Application
        6.2.1 Hospitals and Clinics
        6.2.2 Retail Pharmacies
        6.2.3 E-commerce Platforms
        6.2.4 Other
    6.3 Market Segment by Application
        6.3.1 World Burn and Scald Medicine Production by Application (2020-2031)
        6.3.2 World Burn and Scald Medicine Production Value by Application (2020-2031)
        6.3.3 World Burn and Scald Medicine Average Price by Application (2020-2031)

7 Company Profiles
    7.1 Mebao Pharmaceutical Technology Group
        7.1.1 Mebao Pharmaceutical Technology Group Details
        7.1.2 Mebao Pharmaceutical Technology Group Major Business
        7.1.3 Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product and Services
        7.1.4 Mebao Pharmaceutical Technology Group Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.1.5 Mebao Pharmaceutical Technology Group Recent Developments/Updates
        7.1.6 Mebao Pharmaceutical Technology Group Competitive Strengths & Weaknesses
    7.2 B. Braun
        7.2.1 B. Braun Details
        7.2.2 B. Braun Major Business
        7.2.3 B. Braun Burn and Scald Medicine Product and Services
        7.2.4 B. Braun Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.2.5 B. Braun Recent Developments/Updates
        7.2.6 B. Braun Competitive Strengths & Weaknesses
    7.3 Integra LifeSciences
        7.3.1 Integra LifeSciences Details
        7.3.2 Integra LifeSciences Major Business
        7.3.3 Integra LifeSciences Burn and Scald Medicine Product and Services
        7.3.4 Integra LifeSciences Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.3.5 Integra LifeSciences Recent Developments/Updates
        7.3.6 Integra LifeSciences Competitive Strengths & Weaknesses
    7.4 Jinyao Darentang
        7.4.1 Jinyao Darentang Details
        7.4.2 Jinyao Darentang Major Business
        7.4.3 Jinyao Darentang Burn and Scald Medicine Product and Services
        7.4.4 Jinyao Darentang Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.4.5 Jinyao Darentang Recent Developments/Updates
        7.4.6 Jinyao Darentang Competitive Strengths & Weaknesses
    7.5 Smith & Nephew
        7.5.1 Smith & Nephew Details
        7.5.2 Smith & Nephew Major Business
        7.5.3 Smith & Nephew Burn and Scald Medicine Product and Services
        7.5.4 Smith & Nephew Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.5.5 Smith & Nephew Recent Developments/Updates
        7.5.6 Smith & Nephew Competitive Strengths & Weaknesses
    7.6 Yangtze River Pharmaceutical Group
        7.6.1 Yangtze River Pharmaceutical Group Details
        7.6.2 Yangtze River Pharmaceutical Group Major Business
        7.6.3 Yangtze River Pharmaceutical Group Burn and Scald Medicine Product and Services
        7.6.4 Yangtze River Pharmaceutical Group Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.6.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
        7.6.6 Yangtze River Pharmaceutical Group Competitive Strengths & Weaknesses
    7.7 STADA Thornton & Ross
        7.7.1 STADA Thornton & Ross Details
        7.7.2 STADA Thornton & Ross Major Business
        7.7.3 STADA Thornton & Ross Burn and Scald Medicine Product and Services
        7.7.4 STADA Thornton & Ross Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.7.5 STADA Thornton & Ross Recent Developments/Updates
        7.7.6 STADA Thornton & Ross Competitive Strengths & Weaknesses
    7.8 Kenvue Brands LLC
        7.8.1 Kenvue Brands LLC Details
        7.8.2 Kenvue Brands LLC Major Business
        7.8.3 Kenvue Brands LLC Burn and Scald Medicine Product and Services
        7.8.4 Kenvue Brands LLC Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.8.5 Kenvue Brands LLC Recent Developments/Updates
        7.8.6 Kenvue Brands LLC Competitive Strengths & Weaknesses
    7.9 Changchun Overseas Pharmaceutical Group Co., Ltd.
        7.9.1 Changchun Overseas Pharmaceutical Group Co., Ltd. Details
        7.9.2 Changchun Overseas Pharmaceutical Group Co., Ltd. Major Business
        7.9.3 Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product and Services
        7.9.4 Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.9.5 Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments/Updates
        7.9.6 Changchun Overseas Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
    7.10 Orkla Health
        7.10.1 Orkla Health Details
        7.10.2 Orkla Health Major Business
        7.10.3 Orkla Health Burn and Scald Medicine Product and Services
        7.10.4 Orkla Health Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.10.5 Orkla Health Recent Developments/Updates
        7.10.6 Orkla Health Competitive Strengths & Weaknesses
    7.11 Guangdong Hengjian Pharmaceutical
        7.11.1 Guangdong Hengjian Pharmaceutical Details
        7.11.2 Guangdong Hengjian Pharmaceutical Major Business
        7.11.3 Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product and Services
        7.11.4 Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.11.5 Guangdong Hengjian Pharmaceutical Recent Developments/Updates
        7.11.6 Guangdong Hengjian Pharmaceutical Competitive Strengths & Weaknesses
    7.12 Otsuka Pharmaceutical Co., Ltd.
        7.12.1 Otsuka Pharmaceutical Co., Ltd. Details
        7.12.2 Otsuka Pharmaceutical Co., Ltd. Major Business
        7.12.3 Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
        7.12.4 Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.12.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
        7.12.6 Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    7.13 Tonghua Maoxiang Pharmaceutical Co., Ltd.
        7.13.1 Tonghua Maoxiang Pharmaceutical Co., Ltd. Details
        7.13.2 Tonghua Maoxiang Pharmaceutical Co., Ltd. Major Business
        7.13.3 Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
        7.13.4 Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.13.5 Tonghua Maoxiang Pharmaceutical Co., Ltd. Recent Developments/Updates
        7.13.6 Tonghua Maoxiang Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    7.14 Cipla
        7.14.1 Cipla Details
        7.14.2 Cipla Major Business
        7.14.3 Cipla Burn and Scald Medicine Product and Services
        7.14.4 Cipla Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.14.5 Cipla Recent Developments/Updates
        7.14.6 Cipla Competitive Strengths & Weaknesses
    7.15 Tanabe Mitsubishi Pharmaceuticals
        7.15.1 Tanabe Mitsubishi Pharmaceuticals Details
        7.15.2 Tanabe Mitsubishi Pharmaceuticals Major Business
        7.15.3 Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product and Services
        7.15.4 Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.15.5 Tanabe Mitsubishi Pharmaceuticals Recent Developments/Updates
        7.15.6 Tanabe Mitsubishi Pharmaceuticals Competitive Strengths & Weaknesses
    7.16 Chongqing Xixuan Biotechnology Co., Ltd.
        7.16.1 Chongqing Xixuan Biotechnology Co., Ltd. Details
        7.16.2 Chongqing Xixuan Biotechnology Co., Ltd. Major Business
        7.16.3 Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product and Services
        7.16.4 Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.16.5 Chongqing Xixuan Biotechnology Co., Ltd. Recent Developments/Updates
        7.16.6 Chongqing Xixuan Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
    7.17 Quest Products, LLC
        7.17.1 Quest Products, LLC Details
        7.17.2 Quest Products, LLC Major Business
        7.17.3 Quest Products, LLC Burn and Scald Medicine Product and Services
        7.17.4 Quest Products, LLC Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.17.5 Quest Products, LLC Recent Developments/Updates
        7.17.6 Quest Products, LLC Competitive Strengths & Weaknesses
    7.18 Jianmin Group Yekai Thai Pharmaceutical (Suizhou)
        7.18.1 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Details
        7.18.2 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Major Business
        7.18.3 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product and Services
        7.18.4 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.18.5 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Recent Developments/Updates
        7.18.6 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Competitive Strengths & Weaknesses
    7.19 Acme United Corp.
        7.19.1 Acme United Corp. Details
        7.19.2 Acme United Corp. Major Business
        7.19.3 Acme United Corp. Burn and Scald Medicine Product and Services
        7.19.4 Acme United Corp. Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.19.5 Acme United Corp. Recent Developments/Updates
        7.19.6 Acme United Corp. Competitive Strengths & Weaknesses
    7.20 Dongwha Pharm
        7.20.1 Dongwha Pharm Details
        7.20.2 Dongwha Pharm Major Business
        7.20.3 Dongwha Pharm Burn and Scald Medicine Product and Services
        7.20.4 Dongwha Pharm Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.20.5 Dongwha Pharm Recent Developments/Updates
        7.20.6 Dongwha Pharm Competitive Strengths & Weaknesses
    7.21 China Resources Pharmaceutical Group
        7.21.1 China Resources Pharmaceutical Group Details
        7.21.2 China Resources Pharmaceutical Group Major Business
        7.21.3 China Resources Pharmaceutical Group Burn and Scald Medicine Product and Services
        7.21.4 China Resources Pharmaceutical Group Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.21.5 China Resources Pharmaceutical Group Recent Developments/Updates
        7.21.6 China Resources Pharmaceutical Group Competitive Strengths & Weaknesses
    7.22 Safetec Of America
        7.22.1 Safetec Of America Details
        7.22.2 Safetec Of America Major Business
        7.22.3 Safetec Of America Burn and Scald Medicine Product and Services
        7.22.4 Safetec Of America Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.22.5 Safetec Of America Recent Developments/Updates
        7.22.6 Safetec Of America Competitive Strengths & Weaknesses
    7.23 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.
        7.23.1 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Details
        7.23.2 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Major Business
        7.23.3 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
        7.23.4 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.23.5 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Recent Developments/Updates
        7.23.6 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    7.24 North China Pharmaceutical Hebei Huanuo
        7.24.1 North China Pharmaceutical Hebei Huanuo Details
        7.24.2 North China Pharmaceutical Hebei Huanuo Major Business
        7.24.3 North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product and Services
        7.24.4 North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.24.5 North China Pharmaceutical Hebei Huanuo Recent Developments/Updates
        7.24.6 North China Pharmaceutical Hebei Huanuo Competitive Strengths & Weaknesses
    7.25 Xiangxi Hongcheng Pharmaceutical
        7.25.1 Xiangxi Hongcheng Pharmaceutical Details
        7.25.2 Xiangxi Hongcheng Pharmaceutical Major Business
        7.25.3 Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product and Services
        7.25.4 Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.25.5 Xiangxi Hongcheng Pharmaceutical Recent Developments/Updates
        7.25.6 Xiangxi Hongcheng Pharmaceutical Competitive Strengths & Weaknesses
    7.26 Hebei Aoxing Group Pharmaceuticals
        7.26.1 Hebei Aoxing Group Pharmaceuticals Details
        7.26.2 Hebei Aoxing Group Pharmaceuticals Major Business
        7.26.3 Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product and Services
        7.26.4 Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.26.5 Hebei Aoxing Group Pharmaceuticals Recent Developments/Updates
        7.26.6 Hebei Aoxing Group Pharmaceuticals Competitive Strengths & Weaknesses
    7.27 Jilin Aodong Pharmaceutical Group
        7.27.1 Jilin Aodong Pharmaceutical Group Details
        7.27.2 Jilin Aodong Pharmaceutical Group Major Business
        7.27.3 Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product and Services
        7.27.4 Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.27.5 Jilin Aodong Pharmaceutical Group Recent Developments/Updates
        7.27.6 Jilin Aodong Pharmaceutical Group Competitive Strengths & Weaknesses
    7.28 Beijing Tongrentang
        7.28.1 Beijing Tongrentang Details
        7.28.2 Beijing Tongrentang Major Business
        7.28.3 Beijing Tongrentang Burn and Scald Medicine Product and Services
        7.28.4 Beijing Tongrentang Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.28.5 Beijing Tongrentang Recent Developments/Updates
        7.28.6 Beijing Tongrentang Competitive Strengths & Weaknesses
    7.29 Henan Quanyu Pharmaceuticals
        7.29.1 Henan Quanyu Pharmaceuticals Details
        7.29.2 Henan Quanyu Pharmaceuticals Major Business
        7.29.3 Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product and Services
        7.29.4 Henan Quanyu Pharmaceuticals Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.29.5 Henan Quanyu Pharmaceuticals Recent Developments/Updates
        7.29.6 Henan Quanyu Pharmaceuticals Competitive Strengths & Weaknesses
    7.30 Chengdu First Pharmaceuticals
        7.30.1 Chengdu First Pharmaceuticals Details
        7.30.2 Chengdu First Pharmaceuticals Major Business
        7.30.3 Chengdu First Pharmaceuticals Burn and Scald Medicine Product and Services
        7.30.4 Chengdu First Pharmaceuticals Burn and Scald Medicine Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.30.5 Chengdu First Pharmaceuticals Recent Developments/Updates
        7.30.6 Chengdu First Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Burn and Scald Medicine Industry Chain
    8.2 Burn and Scald Medicine Upstream Analysis
        8.2.1 Burn and Scald Medicine Core Raw Materials
        8.2.2 Main Manufacturers of Burn and Scald Medicine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Burn and Scald Medicine Production Mode
    8.6 Burn and Scald Medicine Procurement Model
    8.7 Burn and Scald Medicine Industry Sales Model and Sales Channels
        8.7.1 Burn and Scald Medicine Sales Model
        8.7.2 Burn and Scald Medicine Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Burn and Scald Medicine Production Value by Region (2020, 2024 and 2031) & (USD Million)
 Table 2. World Burn and Scald Medicine Production Value by Region (2020-2025) & (USD Million)
 Table 3. World Burn and Scald Medicine Production Value by Region (2026-2031) & (USD Million)
 Table 4. World Burn and Scald Medicine Production Value Market Share by Region (2020-2025)
 Table 5. World Burn and Scald Medicine Production Value Market Share by Region (2026-2031)
 Table 6. World Burn and Scald Medicine Production by Region (2020-2025) & (K Units)
 Table 7. World Burn and Scald Medicine Production by Region (2026-2031) & (K Units)
 Table 8. World Burn and Scald Medicine Production Market Share by Region (2020-2025)
 Table 9. World Burn and Scald Medicine Production Market Share by Region (2026-2031)
 Table 10. World Burn and Scald Medicine Average Price by Region (2020-2025) & (US$/Unit)
 Table 11. World Burn and Scald Medicine Average Price by Region (2026-2031) & (US$/Unit)
 Table 12. Burn and Scald Medicine Major Market Trends
 Table 13. World Burn and Scald Medicine Consumption Growth Rate Forecast by Region (2020 & 2024 & 2031) & (K Units)
 Table 14. World Burn and Scald Medicine Consumption by Region (2020-2025) & (K Units)
 Table 15. World Burn and Scald Medicine Consumption Forecast by Region (2026-2031) & (K Units)
 Table 16. World Burn and Scald Medicine Production Value by Manufacturer (2020-2025) & (USD Million)
 Table 17. Production Value Market Share of Key Burn and Scald Medicine Producers in 2024
 Table 18. World Burn and Scald Medicine Production by Manufacturer (2020-2025) & (K Units)
 Table 19. Production Market Share of Key Burn and Scald Medicine Producers in 2024
 Table 20. World Burn and Scald Medicine Average Price by Manufacturer (2020-2025) & (US$/Unit)
 Table 21. Global Burn and Scald Medicine Company Evaluation Quadrant
 Table 22. World Burn and Scald Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2024
 Table 23. Head Office and Burn and Scald Medicine Production Site of Key Manufacturer
 Table 24. Burn and Scald Medicine Market: Company Product Type Footprint
 Table 25. Burn and Scald Medicine Market: Company Product Application Footprint
 Table 26. Burn and Scald Medicine Competitive Factors
 Table 27. Burn and Scald Medicine New Entrant and Capacity Expansion Plans
 Table 28. Burn and Scald Medicine Mergers & Acquisitions Activity
 Table 29. United States VS China Burn and Scald Medicine Production Value Comparison, (2020 & 2024 & 2031) & (USD Million)
 Table 30. United States VS China Burn and Scald Medicine Production Comparison, (2020 & 2024 & 2031) & (K Units)
 Table 31. United States VS China Burn and Scald Medicine Consumption Comparison, (2020 & 2024 & 2031) & (K Units)
 Table 32. United States Based Burn and Scald Medicine Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Burn and Scald Medicine Production Value, (2020-2025) & (USD Million)
 Table 34. United States Based Manufacturers Burn and Scald Medicine Production Value Market Share (2020-2025)
 Table 35. United States Based Manufacturers Burn and Scald Medicine Production (2020-2025) & (K Units)
 Table 36. United States Based Manufacturers Burn and Scald Medicine Production Market Share (2020-2025)
 Table 37. China Based Burn and Scald Medicine Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Burn and Scald Medicine Production Value, (2020-2025) & (USD Million)
 Table 39. China Based Manufacturers Burn and Scald Medicine Production Value Market Share (2020-2025)
 Table 40. China Based Manufacturers Burn and Scald Medicine Production, (2020-2025) & (K Units)
 Table 41. China Based Manufacturers Burn and Scald Medicine Production Market Share (2020-2025)
 Table 42. Rest of World Based Burn and Scald Medicine Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Burn and Scald Medicine Production Value, (2020-2025) & (USD Million)
 Table 44. Rest of World Based Manufacturers Burn and Scald Medicine Production Value Market Share (2020-2025)
 Table 45. Rest of World Based Manufacturers Burn and Scald Medicine Production, (2020-2025) & (K Units)
 Table 46. Rest of World Based Manufacturers Burn and Scald Medicine Production Market Share (2020-2025)
 Table 47. World Burn and Scald Medicine Production Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 48. World Burn and Scald Medicine Production by Type (2020-2025) & (K Units)
 Table 49. World Burn and Scald Medicine Production by Type (2026-2031) & (K Units)
 Table 50. World Burn and Scald Medicine Production Value by Type (2020-2025) & (USD Million)
 Table 51. World Burn and Scald Medicine Production Value by Type (2026-2031) & (USD Million)
 Table 52. World Burn and Scald Medicine Average Price by Type (2020-2025) & (US$/Unit)
 Table 53. World Burn and Scald Medicine Average Price by Type (2026-2031) & (US$/Unit)
 Table 54. World Burn and Scald Medicine Production Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 55. World Burn and Scald Medicine Production by Application (2020-2025) & (K Units)
 Table 56. World Burn and Scald Medicine Production by Application (2026-2031) & (K Units)
 Table 57. World Burn and Scald Medicine Production Value by Application (2020-2025) & (USD Million)
 Table 58. World Burn and Scald Medicine Production Value by Application (2026-2031) & (USD Million)
 Table 59. World Burn and Scald Medicine Average Price by Application (2020-2025) & (US$/Unit)
 Table 60. World Burn and Scald Medicine Average Price by Application (2026-2031) & (US$/Unit)
 Table 61. Mebao Pharmaceutical Technology Group Basic Information, Manufacturing Base and Competitors
 Table 62. Mebao Pharmaceutical Technology Group Major Business
 Table 63. Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product and Services
 Table 64. Mebao Pharmaceutical Technology Group Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 65. Mebao Pharmaceutical Technology Group Recent Developments/Updates
 Table 66. Mebao Pharmaceutical Technology Group Competitive Strengths & Weaknesses
 Table 67. B. Braun Basic Information, Manufacturing Base and Competitors
 Table 68. B. Braun Major Business
 Table 69. B. Braun Burn and Scald Medicine Product and Services
 Table 70. B. Braun Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 71. B. Braun Recent Developments/Updates
 Table 72. B. Braun Competitive Strengths & Weaknesses
 Table 73. Integra LifeSciences Basic Information, Manufacturing Base and Competitors
 Table 74. Integra LifeSciences Major Business
 Table 75. Integra LifeSciences Burn and Scald Medicine Product and Services
 Table 76. Integra LifeSciences Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 77. Integra LifeSciences Recent Developments/Updates
 Table 78. Integra LifeSciences Competitive Strengths & Weaknesses
 Table 79. Jinyao Darentang Basic Information, Manufacturing Base and Competitors
 Table 80. Jinyao Darentang Major Business
 Table 81. Jinyao Darentang Burn and Scald Medicine Product and Services
 Table 82. Jinyao Darentang Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 83. Jinyao Darentang Recent Developments/Updates
 Table 84. Jinyao Darentang Competitive Strengths & Weaknesses
 Table 85. Smith & Nephew Basic Information, Manufacturing Base and Competitors
 Table 86. Smith & Nephew Major Business
 Table 87. Smith & Nephew Burn and Scald Medicine Product and Services
 Table 88. Smith & Nephew Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 89. Smith & Nephew Recent Developments/Updates
 Table 90. Smith & Nephew Competitive Strengths & Weaknesses
 Table 91. Yangtze River Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
 Table 92. Yangtze River Pharmaceutical Group Major Business
 Table 93. Yangtze River Pharmaceutical Group Burn and Scald Medicine Product and Services
 Table 94. Yangtze River Pharmaceutical Group Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 95. Yangtze River Pharmaceutical Group Recent Developments/Updates
 Table 96. Yangtze River Pharmaceutical Group Competitive Strengths & Weaknesses
 Table 97. STADA Thornton & Ross Basic Information, Manufacturing Base and Competitors
 Table 98. STADA Thornton & Ross Major Business
 Table 99. STADA Thornton & Ross Burn and Scald Medicine Product and Services
 Table 100. STADA Thornton & Ross Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 101. STADA Thornton & Ross Recent Developments/Updates
 Table 102. STADA Thornton & Ross Competitive Strengths & Weaknesses
 Table 103. Kenvue Brands LLC Basic Information, Manufacturing Base and Competitors
 Table 104. Kenvue Brands LLC Major Business
 Table 105. Kenvue Brands LLC Burn and Scald Medicine Product and Services
 Table 106. Kenvue Brands LLC Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 107. Kenvue Brands LLC Recent Developments/Updates
 Table 108. Kenvue Brands LLC Competitive Strengths & Weaknesses
 Table 109. Changchun Overseas Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 110. Changchun Overseas Pharmaceutical Group Co., Ltd. Major Business
 Table 111. Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product and Services
 Table 112. Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 113. Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 114. Changchun Overseas Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
 Table 115. Orkla Health Basic Information, Manufacturing Base and Competitors
 Table 116. Orkla Health Major Business
 Table 117. Orkla Health Burn and Scald Medicine Product and Services
 Table 118. Orkla Health Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 119. Orkla Health Recent Developments/Updates
 Table 120. Orkla Health Competitive Strengths & Weaknesses
 Table 121. Guangdong Hengjian Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 122. Guangdong Hengjian Pharmaceutical Major Business
 Table 123. Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product and Services
 Table 124. Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 125. Guangdong Hengjian Pharmaceutical Recent Developments/Updates
 Table 126. Guangdong Hengjian Pharmaceutical Competitive Strengths & Weaknesses
 Table 127. Otsuka Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 128. Otsuka Pharmaceutical Co., Ltd. Major Business
 Table 129. Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
 Table 130. Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 131. Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 132. Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
 Table 133. Tonghua Maoxiang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 134. Tonghua Maoxiang Pharmaceutical Co., Ltd. Major Business
 Table 135. Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
 Table 136. Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 137. Tonghua Maoxiang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 138. Tonghua Maoxiang Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
 Table 139. Cipla Basic Information, Manufacturing Base and Competitors
 Table 140. Cipla Major Business
 Table 141. Cipla Burn and Scald Medicine Product and Services
 Table 142. Cipla Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 143. Cipla Recent Developments/Updates
 Table 144. Cipla Competitive Strengths & Weaknesses
 Table 145. Tanabe Mitsubishi Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 146. Tanabe Mitsubishi Pharmaceuticals Major Business
 Table 147. Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product and Services
 Table 148. Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 149. Tanabe Mitsubishi Pharmaceuticals Recent Developments/Updates
 Table 150. Tanabe Mitsubishi Pharmaceuticals Competitive Strengths & Weaknesses
 Table 151. Chongqing Xixuan Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 152. Chongqing Xixuan Biotechnology Co., Ltd. Major Business
 Table 153. Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product and Services
 Table 154. Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 155. Chongqing Xixuan Biotechnology Co., Ltd. Recent Developments/Updates
 Table 156. Chongqing Xixuan Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
 Table 157. Quest Products, LLC Basic Information, Manufacturing Base and Competitors
 Table 158. Quest Products, LLC Major Business
 Table 159. Quest Products, LLC Burn and Scald Medicine Product and Services
 Table 160. Quest Products, LLC Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 161. Quest Products, LLC Recent Developments/Updates
 Table 162. Quest Products, LLC Competitive Strengths & Weaknesses
 Table 163. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Basic Information, Manufacturing Base and Competitors
 Table 164. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Major Business
 Table 165. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product and Services
 Table 166. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 167. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Recent Developments/Updates
 Table 168. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Competitive Strengths & Weaknesses
 Table 169. Acme United Corp. Basic Information, Manufacturing Base and Competitors
 Table 170. Acme United Corp. Major Business
 Table 171. Acme United Corp. Burn and Scald Medicine Product and Services
 Table 172. Acme United Corp. Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 173. Acme United Corp. Recent Developments/Updates
 Table 174. Acme United Corp. Competitive Strengths & Weaknesses
 Table 175. Dongwha Pharm Basic Information, Manufacturing Base and Competitors
 Table 176. Dongwha Pharm Major Business
 Table 177. Dongwha Pharm Burn and Scald Medicine Product and Services
 Table 178. Dongwha Pharm Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 179. Dongwha Pharm Recent Developments/Updates
 Table 180. Dongwha Pharm Competitive Strengths & Weaknesses
 Table 181. China Resources Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
 Table 182. China Resources Pharmaceutical Group Major Business
 Table 183. China Resources Pharmaceutical Group Burn and Scald Medicine Product and Services
 Table 184. China Resources Pharmaceutical Group Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 185. China Resources Pharmaceutical Group Recent Developments/Updates
 Table 186. China Resources Pharmaceutical Group Competitive Strengths & Weaknesses
 Table 187. Safetec Of America Basic Information, Manufacturing Base and Competitors
 Table 188. Safetec Of America Major Business
 Table 189. Safetec Of America Burn and Scald Medicine Product and Services
 Table 190. Safetec Of America Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 191. Safetec Of America Recent Developments/Updates
 Table 192. Safetec Of America Competitive Strengths & Weaknesses
 Table 193. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 194. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Major Business
 Table 195. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
 Table 196. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 197. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 198. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
 Table 199. North China Pharmaceutical Hebei Huanuo Basic Information, Manufacturing Base and Competitors
 Table 200. North China Pharmaceutical Hebei Huanuo Major Business
 Table 201. North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product and Services
 Table 202. North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 203. North China Pharmaceutical Hebei Huanuo Recent Developments/Updates
 Table 204. North China Pharmaceutical Hebei Huanuo Competitive Strengths & Weaknesses
 Table 205. Xiangxi Hongcheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 206. Xiangxi Hongcheng Pharmaceutical Major Business
 Table 207. Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product and Services
 Table 208. Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 209. Xiangxi Hongcheng Pharmaceutical Recent Developments/Updates
 Table 210. Xiangxi Hongcheng Pharmaceutical Competitive Strengths & Weaknesses
 Table 211. Hebei Aoxing Group Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 212. Hebei Aoxing Group Pharmaceuticals Major Business
 Table 213. Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product and Services
 Table 214. Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 215. Hebei Aoxing Group Pharmaceuticals Recent Developments/Updates
 Table 216. Hebei Aoxing Group Pharmaceuticals Competitive Strengths & Weaknesses
 Table 217. Jilin Aodong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
 Table 218. Jilin Aodong Pharmaceutical Group Major Business
 Table 219. Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product and Services
 Table 220. Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 221. Jilin Aodong Pharmaceutical Group Recent Developments/Updates
 Table 222. Jilin Aodong Pharmaceutical Group Competitive Strengths & Weaknesses
 Table 223. Beijing Tongrentang Basic Information, Manufacturing Base and Competitors
 Table 224. Beijing Tongrentang Major Business
 Table 225. Beijing Tongrentang Burn and Scald Medicine Product and Services
 Table 226. Beijing Tongrentang Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 227. Beijing Tongrentang Recent Developments/Updates
 Table 228. Beijing Tongrentang Competitive Strengths & Weaknesses
 Table 229. Henan Quanyu Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 230. Henan Quanyu Pharmaceuticals Major Business
 Table 231. Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product and Services
 Table 232. Henan Quanyu Pharmaceuticals Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 233. Henan Quanyu Pharmaceuticals Recent Developments/Updates
 Table 234. Henan Quanyu Pharmaceuticals Competitive Strengths & Weaknesses
 Table 235. Chengdu First Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 236. Chengdu First Pharmaceuticals Major Business
 Table 237. Chengdu First Pharmaceuticals Burn and Scald Medicine Product and Services
 Table 238. Chengdu First Pharmaceuticals Burn and Scald Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 239. Chengdu First Pharmaceuticals Recent Developments/Updates
 Table 240. Chengdu First Pharmaceuticals Competitive Strengths & Weaknesses
 Table 241. Global Key Players of Burn and Scald Medicine Upstream (Raw Materials)
 Table 242. Global Burn and Scald Medicine Typical Customers
 Table 243. Burn and Scald Medicine Typical Distributors


List of Figures
 Figure 1. Burn and Scald Medicine Picture
 Figure 2. World Burn and Scald Medicine Production Value: 2020 & 2024 & 2031, (USD Million)
 Figure 3. World Burn and Scald Medicine Production Value and Forecast (2020-2031) & (USD Million)
 Figure 4. World Burn and Scald Medicine Production (2020-2031) & (K Units)
 Figure 5. World Burn and Scald Medicine Average Price (2020-2031) & (US$/Unit)
 Figure 6. World Burn and Scald Medicine Production Value Market Share by Region (2020-2031)
 Figure 7. World Burn and Scald Medicine Production Market Share by Region (2020-2031)
 Figure 8. North America Burn and Scald Medicine Production (2020-2031) & (K Units)
 Figure 9. Europe Burn and Scald Medicine Production (2020-2031) & (K Units)
 Figure 10. China Burn and Scald Medicine Production (2020-2031) & (K Units)
 Figure 11. Japan Burn and Scald Medicine Production (2020-2031) & (K Units)
 Figure 12. Burn and Scald Medicine Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Burn and Scald Medicine Consumption (2020-2031) & (K Units)
 Figure 15. World Burn and Scald Medicine Consumption Market Share by Region (2020-2031)
 Figure 16. United States Burn and Scald Medicine Consumption (2020-2031) & (K Units)
 Figure 17. China Burn and Scald Medicine Consumption (2020-2031) & (K Units)
 Figure 18. Europe Burn and Scald Medicine Consumption (2020-2031) & (K Units)
 Figure 19. Japan Burn and Scald Medicine Consumption (2020-2031) & (K Units)
 Figure 20. South Korea Burn and Scald Medicine Consumption (2020-2031) & (K Units)
 Figure 21. ASEAN Burn and Scald Medicine Consumption (2020-2031) & (K Units)
 Figure 22. India Burn and Scald Medicine Consumption (2020-2031) & (K Units)
 Figure 23. Producer Shipments of Burn and Scald Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2024
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Burn and Scald Medicine Markets in 2024
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Burn and Scald Medicine Markets in 2024
 Figure 26. United States VS China: Burn and Scald Medicine Production Value Market Share Comparison (2020 & 2024 & 2031)
 Figure 27. United States VS China: Burn and Scald Medicine Production Market Share Comparison (2020 & 2024 & 2031)
 Figure 28. United States VS China: Burn and Scald Medicine Consumption Market Share Comparison (2020 & 2024 & 2031)
 Figure 29. United States Based Manufacturers Burn and Scald Medicine Production Market Share 2024
 Figure 30. China Based Manufacturers Burn and Scald Medicine Production Market Share 2024
 Figure 31. Rest of World Based Manufacturers Burn and Scald Medicine Production Market Share 2024
 Figure 32. World Burn and Scald Medicine Production Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 33. World Burn and Scald Medicine Production Value Market Share by Type in 2024
 Figure 34. Ointment
 Figure 35. Spray
 Figure 36. Oil
 Figure 37. Other
 Figure 38. World Burn and Scald Medicine Production Market Share by Type (2020-2031)
 Figure 39. World Burn and Scald Medicine Production Value Market Share by Type (2020-2031)
 Figure 40. World Burn and Scald Medicine Average Price by Type (2020-2031) & (US$/Unit)
 Figure 41. World Burn and Scald Medicine Production Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 42. World Burn and Scald Medicine Production Value Market Share by Application in 2024
 Figure 43. Hospitals and Clinics
 Figure 44. Retail Pharmacies
 Figure 45. E-commerce Platforms
 Figure 46. Other
 Figure 47. World Burn and Scald Medicine Production Market Share by Application (2020-2031)
 Figure 48. World Burn and Scald Medicine Production Value Market Share by Application (2020-2031)
 Figure 49. World Burn and Scald Medicine Average Price by Application (2020-2031) & (US$/Unit)
 Figure 50. Burn and Scald Medicine Industry Chain
 Figure 51. Burn and Scald Medicine Procurement Model
 Figure 52. Burn and Scald Medicine Sales Model
 Figure 53. Burn and Scald Medicine Sales Channels, Direct Sales, and Distribution
 Figure 54. Methodology
 Figure 55. Research Process and Data Source

Companies Mentioned

Mebao Pharmaceutical Technology Group
B. Braun
Integra LifeSciences
Jinyao Darentang
Smith & Nephew
Yangtze River Pharmaceutical Group
STADA Thornton & Ross
Kenvue Brands LLC
Changchun Overseas Pharmaceutical Group Co., Ltd.
Orkla Health
Guangdong Hengjian Pharmaceutical
Otsuka Pharmaceutical Co., Ltd.
Tonghua Maoxiang Pharmaceutical Co., Ltd.
Cipla
Tanabe Mitsubishi Pharmaceuticals
Chongqing Xixuan Biotechnology Co., Ltd.
Quest Products, LLC
Jianmin Group Yekai Thai Pharmaceutical (Suizhou)
Acme United Corp.
Dongwha Pharm
China Resources Pharmaceutical Group
Safetec Of America
Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.
North China Pharmaceutical Hebei Huanuo
Xiangxi Hongcheng Pharmaceutical
Hebei Aoxing Group Pharmaceuticals
Jilin Aodong Pharmaceutical Group
Beijing Tongrentang
Henan Quanyu Pharmaceuticals
Chengdu First Pharmaceuticals